RSS: Beckman Main Calendar
The Beckman Institute is host to many public and private events throughout the year, including the Director's Seminar, a series of public lectures by Beckman researchers; the Thursdays at Twelve-Twenty Concerts, a program of free lunchtime musical performances; and a number of national and international conferences, symposiums and workshops.
The Office of Space Reservations handles the use and scheduling of the 10+ conference rooms available for use within the Institute.
Beckman Main Calendar
skip to events
import, export, and share options
advanced search
view calendar
| week selector | S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|---|
 | 30 | 31 | 1 | 2 | 3 | 4 | 5 |
go to week of Jan 6, 2013 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| go to week of Jan 13, 2013 | 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| go to week of Jan 20, 2013 | 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| go to week of Jan 27, 2013 | 27 | 28 | 29 | 30 | 31 | 1 | 2 |
Event Detail Information
Event Detail Information
Theoretical and Computational Biophysics Group 'Computational molecular biophysics for renewable energy, environmental science and drug design'
Speaker Dr. Jeremy C. Smith, U of Tennessee/Oak Ridge National Lab, Oak Ridge, TN
Date Feb 11, 2013
Time 3:00 pm
Location 3269 Beckman Institute, 405 N. Mathews Ave
Sponsor Klaus Schulten
Contact Nancy Mallon
E-Mail nlborn@ks.uiuc.edu
Phone 244-1586
Event type Seminar
Views 822
Some recent concepts in computational molecular biophysics will be presented, with special emphasis on themes of particular technological importance. We will examine how simulations help us understand and overcome the recalcitrance of biomass in cellulosic biofuel production, and how computational chemistry can be used to characterize the cycling of mercury in the environment. The combination of neutron scattering with simulation is used to understand dynamical aspects of the protein glass transition. The change in thermodynamics on ligand binding to a protein is discussed, together with prospects for drug design using exascale supercomputers.